| EDI Committee Action Plan | ABN EDI Committee | 2023 | EDI |
| EDI Strategy | ABN EDI Committee | 2022 | EDI |
| Cannabis-based products for medicinal use - NHSE guidelines to clinicians |
| 2018 | Clinical Practice |
| Epanutin oral suspension (Pfizer) temporary interruption |
| 2018 | Medication |
| ABN message re Epanutin oral suspension (Pfizer) temporary interruption Oct 2018 |
| 2018 | Medication |
| ABN statement on use of marijuana (cannabis) related products in the treatment of complex epilepsies | ABN / Sanjay Sisodiya | 2018 | Epilepsy |
| Acute Neurology Services Survey |
| 2017 | Acute Neurology |
| Morbidity and Mortality |
| 2016 | |
| ABN Neurology Commissioning Toolkit |
| 2016 | |
| ABN statement on use of sodium valproate in pregnancy |
| 2016 | |
| Neurology Commissioning Toolkit (NCT) |
| 2016 | |
| ABN statement on the NICE MS Quality Standards |
| 2016 | |
| Revalidation for Physicians |
| 2015 | |
| MS Guidelines |
| 2015 | |
| Revised Guidelines for Prescribing Disease-Modifying Treatments in Multiple Sclerosis | Professor Neil Scolding Co-authors: -
David Barnes, Sarah Cader, Jeremy Chataway,
Abhijit Chaudhuri, Alasdair Coles, Gavin Giovannoni,
David Miller, Waqar Rashid, Klaus Schmierer,Abdullah Shehu,
Eli Silber, Carolyn Young, John Zajicek
| 2015 | |
| Myasthenia gravis guidelines |
| 2015 | |
| Specialty Training Curriculum for Neurology |
| 2015 | |
| Learning about Neurological Disorders |
| 2015 | |
| Acute Neurology Survey | Geraint Fuller, Joanne Lawrence | 2014 | |
| ABN Guidelines for unscheduled care and non urgent neurological conditions | | 2014 | |
| ABN Quality Standards | | 2014 | |
| ABN Job planning for NHS consultant neurologists and clinical academic neurologists | Gareth Llewelyn and Lucy Kinton | 2014 | |
| Revalidation for Physicians |
| 2013 | |
| How UK neurologists can and should contribute to the acute care of patients with stroke and transient ischaemic attack |
| 2012 | |
| Local adult neurology services for the next decade | ABN & RCP | 2011 | |
| Specialty Training Curriculum for Neurology | | 2010 | |
| General Medical Components of Neurology Training | | 2006 | |
| Guidelines for the Use of Intravenous Immunoglobulin in Neurological Diseases | | 2005 | |
| Academic neurology departments in the United Kingdom | ABN Clinical Research and Academic Committee (CRAC) | 2005 | |
| DVLA Advice relevant to the withdrawal or change of anticonvulsants | Dr Heather G Major | 2003 | |
| Genetic Services for Neurological Disorders |
| 2003 | |
| Critical Care for Neurological Patients | Graham Venables | 2003 | |
| GENETIC SERVICES FOR NEUROLOGICAL DISORDERS | ABN and Clinical Genetics Society | 2003 | |
| The medical management of motor neurone disease – a UK perspective of current practice | MND Special Interest Group | 2002 | |
| ABN Guidelines for the use of Intravenous Immunoglobulin in Neurological Diseases | | 2002 | |
| ABN Guidelines for the use of Beta Interferons and Glatiramer Acetate in Multiple Sclerosis | ABN MS Advisory Group | 2001 | |
Neurology in the United Kingdom - Towards 2000 and beyond
| |
| |
Response to the NSF for Long Term Conditions
| |
| |
| Learning about Disorders of the Nervous System | | | |
| UK Neurology – the next ten years | | | |
| Academic neurology in the United Kingdom - Threats, opportunities and recommendations | | | |
| Acute Neurological Emergencies in Adults | | | |
| Neurology in the United Kingdom - Towards 2000 and beyond | | | |
| Neurology in the United Kingdom - Numbers | | | |
| The Place of Research in the Training of Neurologists | | | |
| Teaching Neurology in the 21st Century | | | |
| Guidelines for the care of patients with common neurological disorders in the United Kingdom | | | |
